History
  • No items yet
midpage
2025-1076-LWW
Del. Ch.
Jul 9, 2026
Read the full case

Background

  • Axsome Therapeutics disclosed regulatory setbacks for its AXS-07 migraine drug by April 25, 2022, and its stock dropped after the FDA reported unresolved CMC issues. 1
  • Plaintiffs claim Axsome and its officers made materially false or misleading statements from 2019 to April 2022 about AXS-07’s NDA prospects and CMC status. 2
  • A stockholder filed a federal securities class action in 2022, and two stockholders later filed a consolidated federal derivative action that remained stayed during the securities case. 3
  • Wickstrom sent a books-and-records demand on April 24, 2025, Gildea served one on May 2, 2025, and Axsome produced documents in September 2025. 4
  • Wickstrom filed this Delaware derivative action on September 23, 2025, Gildea filed six days later, and defendants moved to dismiss. 5
  • The court held the claims accrued by April 22, 2022, were filed after the three-year limitations period, and were time-barred by laches. 6

Issues

Issue Plaintiff's Argument Defendant's Argument Held
When did the fiduciary-duty claims accrue? 7 Claims accrued only when plaintiffs learned the truth through later demand responses. Claims accrued when the challenged statements were made. Claims accrued by April 22, 2022, when the statements were disseminated. 8
Did inquiry notice toll limitations? 9 The limitations period was tolled until suit because the fraud was not fully revealed sooner. Inquiry notice arose by April 25, 2022, ending any tolling. Tolling ended by April 25, 2022; the suit was still untimely. 10
Did the Section 220 demands equitably toll limitations? 11 Serving books-and-records demands suspended limitations until filing suit. Only a diligent Section 220 action can toll; out-of-court demands do not. No tolling; the demands were untimely or improperly served and not diligently pursued. 12
Were defendants prejudiced by the late filing? 13 Parallel federal derivative litigation eliminated any prejudice. Late filing presumes prejudice, compounded by parallel litigation. Prejudice is presumed and unrebutted; laches bars the claims. 14

Key Cases Cited

  • U.S. Cellular Inv. Co. of Allentown v. Bell Atl. Mobile Sys., Inc., 677 A.2d 497 (Del. 1996) (laches requires unreasonable delay causing material prejudice 15)
  • Hudak v. Procek, 806 A.2d 140 (Del. 2002) (defendants generally bear the burden on laches 16)
  • Kraft v. WisdomTree Invs., Inc., 145 A.3d 969 (Del. Ch. 2016) (equity gives great weight to the analogous statute of limitations 17)
  • Sutherland v. Sutherland, 2010 WL 1838968 (Del. Ch. 2010) (breach-of-fiduciary-duty claims accrue at the time of the wrongful act 18)
  • Technicorp Int’l II, Inc. v. Johnston, 2000 WL 713750 (Del. Ch. 2000) (pending litigation to ascertain facts can toll limitations 19)
  • Firemen’s Ret. Sys. of St. Louis v. Sorenson, 2021 WL 4593777 (Del. Ch. 2021) (service of a books-and-records demand alone does not toll limitations 20)
  • Lebanon Cnty. Empls.’ Ret. Fund v. Collis, 287 A.3d 1160 (Del. Ch. 2022) (stockholders may receive tolling credit for diligently pursuing books and records 21)
  • Moelis & Co. v. W. Palm Beach Firefighters’ Pension Fund, 2026 WL 184868 (Del. 2026) (late-filing plaintiffs are presumed prejudiced absent extraordinary circumstances 22)
Read the full case

Case Details

Case Name: In Re Axsome Therapeutics, Inc. Stockholder Derivative Litigation
Court Name: Court of Chancery of Delaware
Date Published: Jul 9, 2026
Citation: 2025-1076-LWW
Docket Number: 2025-1076-LWW
Court Abbreviation: Del. Ch.
Log In